Volume 25, Issue 1 - Authors and Authorship

The sun never sets on transparency

Authors: Kim Pepitone, Brian P Sharkey

Abstract

Download the full article

References

1. Battisti WP, Wager E, Baltzer L, et al. Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3Good Publication Practice for Company- Sponsored Research (GPP3). Annals of Internal Medicine. 2015;163(6): 461-464.
2. ICMJE. Recommend at ions for the conduct, reporting, editing, and publication of scholarly work in medical journals. 2013; Available from: http://www.ICMJE.org
3. United States 111 Congress HR 3590. Patient protection and affordable care act. 2010:111-148.
4. Centers for Medicare and Medicaid Services. Federal register. Department of Health and Human Services; 2013:9457-9528.
5. Jarvies D, Coombes R, Stahl-Timmins W. Open Payments goes live with pharma to doctor fee data: first analysis. BMJ (Clinical research ed.). 2014-10- 01 16:46:40 2014;349.
6. Morain SR, Flexner C, Kass NE, Sugarman J. Forecast for the Physician Payment Sunshine Act: Partly to Mostly Cloudy?Forecast for the Physician Payment Sunshine Act. Annals of Internal Medicine. 2014;161(12): 915-916.
7. Centers for Medicare and Medicaid Services. CMS implements final rule change for open payments. In: Services CfMaM, ed. Vol Pubilc law no. 111- 152: Centers for Medicare and Medicaid Services; 2014.
8. Andrews RE, Schwartz AY, Meehan P, et al. Final Sunshine Act letter to Marilyn Tavenner. 2014.
9. Upton F. HR6-21st century cures act. 2015.
10. Grassley C. S.213-Provider Payment Sunshine Act. 2015.
11. Campbell DJ, Sharkey BP. Ready or not, full speed ahead for the global transparency movement. 2015; Available from: http://porziolifesciences.com/resources/publications
12. European Federation of Pharma ceut - ical Industries and Associations. EFPIA HCP/HCO disclosure code. 2014:1- 15.
13. European Federation of Pharmaceutical Industries and Associations. EFPIA code on disclosure of transfers of value from pharma - ceutical companies to healthcare professionals and healthcare organisations: Frequently asked questions. 2014; Available from: http://transparency.efpia.eu/countries/download/11/document_2/faq–disclosure-code.pdf
14. The International Society for Medical Publication Professionals. ISMPP Sunshine Act information update. 2014; Available from: http://www.ismpp.org/assets/docs/Inititives/Sunshine_Act/sunshine%20act%20interpretation%20update_february%202014_final.pdf
15. Toroser D, DeTora L, Cairns A, et al. The Sunshine Act and medical publications: Guidance from professional medical associations. Postgrad Med. 2015/11/04 2015;127(7):752-757.
16. Wechsler R, Hauser RA, French J, the Clinician Investigator C. Who is helping whom? Manuscript support and transfer of value. Annals of Neurology. 2015;77(2):353-355.
17. Ratain MJ. Forecasting unanticipated consequences of “the Sunshine Act”: mostly cloudy. JCO. 2014;32(22): 2293-2295.